Intravitreal injection injection has become the most accepted ophthalmic procedure in the treatment of DR, and in particular, for the administration of anti-VEGF agents in neovascular age-related macular degeneration, and other various vascular disorders (McCannel, 2011). This evidence concerns the gene VEGFA and wet macular degeneration.